Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Injectable Nanobody Wins FDA Approval for Myasthenia Gravis

(MedPage Today) -- The FDA on Friday approved injectable gefurulimab (Klygefa), a dual-binding nanobody that blocks complement component 5 (C5) activation, to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR...

Injectable Nanobody Wins FDA Approval for Myasthenia Gravis

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Friday 13 November →